Product NDC: | 0225-0295 |
Proprietary Name: | ANASPAZ |
Non Proprietary Name: | HYOSCYAMINE SULFATE |
Active Ingredient(s): | .125 mg/1 & nbsp; HYOSCYAMINE SULFATE |
Administration Route(s): | ORAL; SUBLINGUAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0225-0295 |
Labeler Name: | BF ASCHER AND CO INC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 19730102 |
Package NDC: | 0225-0295-20 |
Package Description: | 500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0225-0295-20) |
NDC Code | 0225-0295-20 |
Proprietary Name | ANASPAZ |
Package Description | 500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE, PLASTIC (0225-0295-20) |
Product NDC | 0225-0295 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | HYOSCYAMINE SULFATE |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL; SUBLINGUAL |
Start Marketing Date | 19730102 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | BF ASCHER AND CO INC |
Substance Name | HYOSCYAMINE SULFATE |
Strength Number | .125 |
Strength Unit | mg/1 |
Pharmaceutical Classes |